Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide

Circulation

Volumn 105, Issue 18, 2002, Pages 2185-2191

  Matsunaga, Toshiro ^a   Weihrauch, Dorothee W ^a   Moniz, Melinda C ^a   Tessmer, John ^a   Warltier, David C ^a   Chilian, William M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Collateral circulation; Growth factors; Metalloproteinases; Nitric oxide

Indexed keywords

ANGIOSTATIN; GELATINASE A; GELATINASE B; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; DOG; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GROWTH INHIBITION; HEART MUSCLE ISCHEMIA; IN VITRO STUDY; IN VIVO STUDY; INTERSTITIAL FLUID; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANGIOGENESIS INHIBITORS; ANGIOSTATINS; ANIMALS; CAPILLARIES; CELL DIVISION; CELLS, CULTURED; COLLATERAL CIRCULATION; CORONARY CIRCULATION; DOGS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR SPACE; FEMALE; HUMANS; KINETICS; MALE; MATRIX METALLOPROTEINASES; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEPTIDE FRAGMENTS; PLASMINOGEN;

EID: 0037035480     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000015856.84385.E9     Document Type: Article

References (34)

1. Clinical trial in coronary angiogenesis: Issues, problems, consensus an expert panel summary
2. The role of nitric oxide in atherosclerosis
3. Atherosclerosis-associated endothelial dysfunction
4. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia
5. Nitric oxide production contributes to the angiogenic properties vascular endothelial growth factor in human endothelial cells
6. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide
7. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer
8. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis
9. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
10. Angiostatin induces and sustains dormancy of human primary tumors in mice
11. Macrophage-derived metalloproteinase is responsible for the generation of angiostatin in Lewis lung carcinoma
12. Diurnal variations in angiostatin in human tear fluid: A possible role in prevention of corneal neovascularization
13. Angiostatin fragments in urine from patients with malignant disease
14. Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance
15. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9)
16. Increased expression of matrix metalloproteinase and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
17. Identification of 92-kDa gelatinase in human coronary atherosclerotic lesions: Association of active enzyme synthesis with unstable angina
18. Temporal dependence of coronary collateral development
19. Repetitive coronary artery occlusions induce release of growth factors into the myocardial interstitium
20. Fluorescent tracer for microcirculatory vessels in nonperfused thin muscles and sectioned muscle
21. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor
22. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: Implication for atherosclerotic plaque stability
23. Capillary growth in anemia-induced ventricular wall remodeling in the rat heart
24. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188
25. Selective downregulation of VEGF-A165, VEGF-R1, and decreased capillary density in patients with dilative but not ischemic cardiomyopathy
26. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium
27. Role of endothelial nitric oxide synthase in endothelial cell migration
28. Nitric oxide: An endothelial cell survival factor
29. vβ3 integrin expression on endothelial cells
30. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation
31. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in human
32. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease
33. Hypercholesterolemia increases endothelial superoxide anion production
34. Expression of human macrophage metalloproteinase gene in hepatocellular carcinoma: Correlation with angiostatin generation and its clinical significance